Sept 10 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS RECEIVES HEALTH CANADA APPROVAL OF XYDALBA™ (DALBAVANCIN HYDROCHLORIDE)
Sept 10 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS RECEIVES HEALTH CANADA APPROVAL OF XYDALBA™ (DALBAVANCIN HYDROCHLORIDE)